Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination.
about
The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adultsSeasonal inactivated influenza virus vaccinesSafety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trialsSafety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyAn evaluation of the emerging vaccines against influenza in children.An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines.Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.Strategies for mitigating an influenza pandemic with pre-pandemic H5N1 vaccines.Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.Estimation of influenza vaccine effectiveness from routine surveillance data.Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons.Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in childrenDifferences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal miceAssessing parents' knowledge and attitudes towards seasonal influenza vaccination of children before and after a seasonal influenza vaccination effectiveness study in low-income urban and rural Kenya, 2010-2011.Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young childrenNebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose.Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical TrialSafety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjectsInfluenza vaccine in patients with asthma.Rituximab-treated patients have a poor response to influenza vaccinationCorrelation of cellular immune responses with protection against culture-confirmed influenza virus in young children.Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons.Adverse events associated with intranasal influenza vaccine in the United States.Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in childrenThe ins and outs of universal childhood influenza vaccination.Cluster of influenza A cases in vaccinated population of adults in Virology Laboratory in Glasgow in December 2012.Comparison of immunogenicity and reactogenicity of split versus subunit influenza vaccine in Korean children aged 6-35 months.
P2860
Q24622008-27145229-0410-4005-9D71-D717C93B33DBQ24652665-AD4F0041-DCA0-4949-9373-F626C6D51242Q28748654-42646D6A-FF39-4B50-9933-21E3FE738C66Q28751886-7B0CB3CA-6FDC-4B88-9D0A-D3AE7C07CBCCQ30359375-D8166B02-C574-4384-9513-C7281610776AQ30372776-9BFED12F-12A2-42F9-BFE6-DC069FFC30ADQ30377041-10A3C30B-E1F4-45A2-923B-881F45F668A0Q30380700-FFE65AEF-A67B-4D70-A119-926CE163278DQ30398281-EBCCDE2A-7096-456D-AE69-C299B0BD6EC5Q33424462-86373937-F2B2-4B36-A588-260484A40A4FQ33541763-C60BC5C2-444D-4DF4-BF0C-169526185139Q33603662-A58E7E3D-A242-4254-A6B9-58550D54D858Q33883224-3875A8D2-3438-4C63-8422-8037949FE222Q34059308-F2E00A53-9E63-496B-8938-4666B7FA50C6Q34687309-EA433A72-A9BE-4701-AD9F-D09170FFFFD7Q35167127-E035FBE4-2822-49E8-BD2B-4D5FFA04F052Q35798811-B1B9A3B1-A86A-4B0F-87CD-FD809D2F2B06Q36009631-439E4D98-2C78-4C21-BBF6-222F50D55629Q36009663-DAF2F21C-6161-494A-87D1-9E33BE242D4CQ36256314-1135B1C1-52D2-4DED-BFC1-259FC94182C0Q36295456-2DA8DAB3-0616-4B05-A7A0-C284D3D8F1EAQ36383823-8A783B86-40DD-4CB4-B1A8-A3A0B1A655BCQ36589247-FCEA9CCE-732F-4167-AE2B-2AFD522724DCQ36746934-CEBA9578-5134-42C8-BDC7-B81B4304680FQ36964157-398D5330-3458-4FBF-A13A-983035FF906FQ37362624-4254EA6B-19D9-4B4E-9F6C-B860E9ECA2BBQ37478405-3C41814C-9E13-4132-94E1-A82E9C07E2ACQ37946432-DC4A14EC-54CC-4BE5-89DD-632C0CE003F0Q42222636-FF0AB2E6-ACB4-4767-A47B-43A5174BBE40Q43171293-10C61E51-9FB6-4F38-BB63-8FFFD32EE794
P2860
Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Safety and efficacy of trivale ...... ew era of routine vaccination.
@ast
Safety and efficacy of trivale ...... ew era of routine vaccination.
@en
type
label
Safety and efficacy of trivale ...... ew era of routine vaccination.
@ast
Safety and efficacy of trivale ...... ew era of routine vaccination.
@en
prefLabel
Safety and efficacy of trivale ...... ew era of routine vaccination.
@ast
Safety and efficacy of trivale ...... ew era of routine vaccination.
@en
P1476
Safety and efficacy of trivale ...... ew era of routine vaccination.
@en
P2093
Kenneth M Zangwill
P304
P356
10.1097/01.INF.0000116292.46143.D6
P577
2004-03-01T00:00:00Z